黑石集团注资5亿美元助力MannKind推进糖尿病治疗研发

DoNews
Aug 07

近日,黑石集团Blackstone与糖尿病治疗产品研发商MannKind达成战略融资协议,投资金额高达5亿美元。MannKind专注于为糖尿病患者开发创新疗法,其旗下产品包括BluHale®技术和吸入式胰岛素AFREZZA®。此次合作将加速MannKind在糖尿病治疗领域的技术研发与市场拓展,为全球患者提供更多高效治疗方案。黑石集团的资金支持凸显了市场对生物医药领域的持续关注,也为MannKind...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10